Afya Limited - AFYA STOCK NEWS

Afya Limited (Nasdaq: AFYA) announces the acquisition of 23,074,134 Class B common shares from Crescera Educacional by Bertelsmann. This strategic transaction allows Bertelsmann to enhance its influence in Afya, having held an indirect stake since inception. Following the acquisition, Bertelsmann can appoint three board members. The deal is pending antitrust approval and includes leadership adjustments, with Daulins Emílio reappointed and Paulo Passoni joining the board. The collaboration aims to strengthen Afya's position in the medical education sector.

Afya Limited (Nasdaq: AFYA) has closed its acquisition of Sociedade Padrão de Educação Superior Ltda (UNIFIPMoc and Fip Guanambi) for R$360 million, which includes R$31.1 million in net debt. This acquisition adds 160 medical school seats, increasing total seats to 2,303, potentially 2,611 with pending approvals. Net revenue for UNIFIPMoc was R$110 million in 2020, with a projection of R$121 million for 2024. The acquisition aims for an EV/EBITDA of 5.1x at maturity, enhancing Afya's position in Brazil's medical education sector.

Afya Limited (Nasdaq: AFYA) reported strong 1Q21 results, with adjusted net revenue rising 47.8% year-over-year to R$402.5 million and an adjusted EBITDA increase of 47.6% to R$207.7 million, maintaining a margin of 51.6%. The company experienced a significant rise in medical students, up 61.5% to 12,852. Notably, the digital business expanded by 43%, aided by strategic acquisitions, including UNIGRANRIO. Afya reaffirmed its guidance for 1H21, projecting net revenue between R$740 million and R$780 million, signaling positive growth expectations.

Afya announced its acquisition of 100% of Universidade do Grande Rio Professor José de Souza Herdy (UNIGRANRIO) for R$700 million. The payment structure includes 60% in cash and 40% in annual installments. UNIGRANRIO adds 308 medical school seats, raising Afya's total to 2,611, with a projected CAGR of 9% from 2020 to 2026. The projected net revenue for UNIGRANRIO in 2023 stands at R$343.2 million, largely from medical courses. This acquisition strengthens Afya’s presence in Rio de Janeiro and enhances its position in the medical education sector.

Afya Limited (Nasdaq: AFYA) has acquired 100% of Shosp, a Brazilian clinical management software provider, for R$5.98 million in cash. Shosp, which has over 450 clinics and 2,800 active users, generates an annual recurring revenue (ARR) of R$1.8 million. The migration of Shosp's users to iClinic’s platform aims to enhance Afya's revenue cycle management. An additional earn-out of R$1.793 million is possible based on user migration and new feature implementations within 24 months.

Afya Limited (Nasdaq: AFYA), Brazil's leading medical education group, announced a significant investment from SoftBank Latin America Fund totaling US$150 million in Series A perpetual convertible preferred shares. This transaction includes the sale of 2,270,208 Class A common shares from Crescera Educacional and the Esteves Family to SoftBank, resulting in SoftBank owning approximately 8.4% of Afya's total shares (on an as-converted basis). Paulo Passoni of SoftBank will join Afya's board within the next 30 days.

Afya Limited (Nasdaq: AFYA) announced the release of its first quarter 2021 financial results for the period ending March 31, 2021, scheduled for May 27, 2021, after market close. A conference call will follow on May 28 at 11:00 AM EDT, with details to be disclosed soon. The webcast will be available on the Investor Relations section of Afya's website. Afya is recognized as a leading medical education group in Brazil, providing a comprehensive ecosystem for medical students and professionals.

Afya Limited (Nasdaq: AFYA), Brazil's largest medical education group, announced a significant investment from SoftBank Latin America Fund totaling R$822 million (about $150 million) in Series A preferred shares. This investment is anticipated to enhance Afya's growth and digital health strategy, enabling the company to pursue acquisitions and further technological advancements. Following the deal, SoftBank will hold approximately 8.4% of Afya's total shares. Paulo Passoni from SoftBank is set to join Afya's board within 30 days, aligning interests in the growing healthcare digital services market.